Fluidinova is a high technology engineering manufacturer company specialized in high quality and high purity nano Hydroxyapatite as a raw-material for medical, cosmetics or other applications, in both...
Inframat® Corporation ("IMC") is an emerging technology company founded in 1996 to develop nanostructured materials to improve performance and extend the life of coated components used throughout the...
Berkeley Advanced Biomaterials, Inc. (BAB) was incorporated in the state of California in October 1996. BAB specializes in producing hydroxyapatite (HAP) and calcium-based materials. The company has...
Promimic is a biomaterial company founded in 2004 as a spin-off from research performed at Chalmers University of Technology in Gothenburg, Sweden. The company develops and markets a new generation of...
Nanotechnology has opened up innovative techniques for producing bone-like synthetic nanopowders and hydroxyapatite coatings. Although not called nanopowders, nanoscale materials have existed since...
http://www.azonano.com/article.aspx?ArticleID=2493 | 7 Jan 2010
Contemporary development of metallic implant materials is driven by the biocompatibility requirements and also by the need for improved mechanical performance of biomedical implants.
http://www.azonano.com/article.aspx?ArticleID=2453 | 22 Nov 2009
Nano Labs Corp. is pleased to announce today the development of a new nanotechnology to convert eggshells into hydroxyapatite, which is a material employed for endodontics, restorative dentistry...
http://www.azonano.com/news.aspx?newsID=27379 | 17 May 2013
Research and Markets has announced the addition of the "Global Market Report of nanometer/micrometer Hydroxyapatite" report to their offering.
Global Market Report of nanometer/micrometer...
http://www.azonano.com/news.aspx?newsID=31782 | 19 Dec 2014
By Cameron Chai
Pioneer Surgical, a company specializing in medical devices, has announced the start of human clinical study of its three-dimensionally shaped bone graft product called nanOss...
http://www.azonano.com/news.aspx?newsID=24046 | 7 Jan 2012
MIV Therapeutics, a leading developer of next-generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, today announced the...
http://www.azonano.com/news.aspx?newsID=4206 | 1 Jun 2007